Will GLP-1 Analogues and SGLT-2 Inhibitors Become New Game Changers for Diabetic Retinopathy?

Diabetic retinopathy (DR) is the most frequent microvascular complication of diabetes mellitus (DM), estimated to affect approximately one-third of the diabetic population, and the most common cause of preventable vision loss. The available treatment options focus on the late stages of this complica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wołos-Kłosowicz, Katarzyna, Matuszewski, Wojciech, Rutkowska, Joanna, Krankowska, Katarzyna, Bandurska-Stankiewicz, Elżbieta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604821/
https://www.ncbi.nlm.nih.gov/pubmed/36294503
http://dx.doi.org/10.3390/jcm11206183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604821/
https://www.ncbi.nlm.nih.gov/pubmed/36294503
http://dx.doi.org/10.3390/jcm11206183

Ejemplares similares